21 General introduction REFERENCES 1. Brennan P, Davey-Smith G. Identifying Novel Causes of Cancers to Enhance Cancer Prevention: New Strategies Are Needed. J Natl Cancer Inst. 2022;114(3):353-60. 2. Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA: A Cancer Journal for Clinicians. 2023;73(1):17-48. 3. Pashayan N, Pharoah PDP. The challenge of early detection in cancer. Science. 2020;368(6491):589-90. 4. Tran KB, Lang JJ, Compton K, Xu R, Acheson AR, Henrikson HJ, et al. The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet. 2022;400(10352):563-91. 5. Rodríguez J, Avila J, Rolfo C, Ruíz-Patiño A, Russo A, Ricaurte L, et al. When Tissue is an Issue the Liquid Biopsy is Nonissue: A Review. Oncology and Therapy. 2021;9(1):89-110. 6. Pantel K, Alix-Panabières C. Liquid biopsy and minimal residual disease—latest advances and implications for cure. Nature Reviews Clinical Oncology. 2019;16(7):409-24. 7. Siravegna G, Mussolin B, Venesio T, Marsoni S, Seoane J, Dive C, et al. How liquid biopsies can change clinical practice in oncology. Annals of Oncology. 2019;30(10):1580-90. 8. Tivey A, Church M, Rothwell D, Dive C, Cook N. Circulating tumour DNA — looking beyond the blood. Nature Reviews Clinical Oncology. 2022;19(9):600-12. 9. Serrano B, Ibáñez R, Robles C, Peremiquel-Trillas P, de Sanjosé S, Bruni L. Worldwide use of HPV self-sampling for cervical cancer screening. Preventive Medicine. 2022;154:106900. 10. Issa IA, Noureddine M. Colorectal cancer screening: An updated review of the available options. World journal of gastroenterology. 2017;23(28):5086. 11. Mikeska T, Craig JM. DNA Methylation Biomarkers: Cancer and Beyond. Genes. 2014;5(3):82164. 12. Hanahan D, Weinberg RA. The Hallmarks of Cancer. Cell. 2000;100(1):57-70. 13. Hanahan D, Weinberg Robert A. Hallmarks of Cancer: The Next Generation. Cell. 2011;144(5):646-74. 14. Hanahan D. Hallmarks of Cancer: New Dimensions. Cancer Discovery. 2022;12(1):31-46. 15. Herman JG, Baylin SB. Gene Silencing in Cancer in Association with Promoter Hypermethylation. New England Journal of Medicine. 2003;349(21):2042-54. 16. Das PM, Singal R. DNA Methylation and Cancer. Journal of Clinical Oncology. 2004;22(22):4632-42. 17. Smith ZD, Meissner A. DNA methylation: roles in mammalian development. Nature Reviews Genetics. 2013;14(3):204-20. 18. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev. 2002;16(1):6-21. 19. Martin EM, Fry RC. Environmental Influences on the Epigenome: Exposure- Associated DNA Methylation in Human Populations. Annual Review of Public Health. 2018;39(1):309-33. 20. Jones MJ, Goodman SJ, Kobor MS. DNA methylation and healthy human aging. Aging Cell. 2015;14(6):924-32. 1
RkJQdWJsaXNoZXIy MjY0ODMw